Abstract:More than 95% of ATP consumed in the heart is derived from oxidative phosphorylation (OxPhos) in the mitochondria. Besides over a thousand proteins encoded by nuclear DNA, mitochondrial gene expression machinery generates 13 proteins for the OxPhos system that employs mitochondrial ribosomal proteins for translation. Mitochondrial ribosome protein S5 (MRPS5) encoded by MRPs gene family, is located at the mammalian mitochondrial ribosome 28S subunit and its importance has not been explored in the heart. Western blotting showed that MRPS5 expression was decreased in TAC-induced hypertrophic mouse hearts ( in vivo ), and in phenylephrine or isoproterenol-stimulated cardiomyocytes ( in vitro ). In the failing hearts of patients, Mrps5-mediated mt-CO1 was markedly decreased as well. To determine the functional role of MRPS5 in the heart, we generated an inducible cardiac-specific knockout mouse and showed that Mrps5-deficient mice developed time-dependent cardiac hypertrophy, fibrosis and heart failure. Mitochondria in the Mrps5-deficient adult cardiomyocytes exhibited membrane swelling and cristae collapsed together with decreased oxygen consumption and ATP production. Mitochondrial calcium homeostasis was also disrupted. Combined analysis of transcriptomics and metabolomics spatiotemporally identified 20 potential target genes associated with Mrps5 deficiency-mediated cardiac pathological processes. Through in vivo functional screening via adeno-associated virus (AAV) mediated gene delivery, we further narrowed down and confirmed that Kruppel-like factor 15 (Klf15) remarkably rescued cardiac phenotype in the Mrps5-deficient mice with maintained mitochondrial homeostasis, suppressed cardiac hypertrophy and fibrosis, as well as preserved cardiac function. Further RNA-sequencing and biochemical analysis mechanistically revealed that genes involved in glycolysis/ gluconeogenesis, PPAR signaling pathway and biosynthesis of amino acids, markedly altered when exploited AAV-Klf15 gene therapy in Mrps5-deficient mice heart. Our results demonstrates Mrps5 is essential for mitochondrial homeostasis and cardiac function and uncovers Klf15 as a potential therapeutic target for treating cardiac mitochondrial diseases.

Ablation of Mto1 in zebrafish exhibited hypertrophic cardiomyopathy manifested by mitochondrion RNA maturation deficiency

Mutation in MTO1 involved in tRNA modification impairs mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae.

Deletion of Mtu1 (trmu) in Zebrafish Revealed the Essential Role of Trna Modification in Mitochondrial Biogenesis and Hearing Function

The Defective Expression of Gtpbp3 Related to Trna Modification Alters the Mitochondrial Function and Development of Zebrafish

Identification and Characterization of Mouse MTO1 Gene Related to Mitochondrial Trna Modification.

Mto1 Worked As A Modifier in the Aminoglycosides Sensitivity of Yeast Carrying A Mitochondrial 15s Rrna C1477g Mutation

Mutations in MTO2 Related to Trna Modification Impair Mitochondrial Gene Expression and Protein Synthesis in the Presence of a Paromomycin Resistance Mutation in Mitochondrial 15 S Rrna

Deletion of the MTO2 gene related to tRNA modification causes a failure in mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae.

Isolation and Characterization of the Putative Nuclear Modifier Gene MTO1 Involved in the Pathogenesis of Deafness-associated Mitochondrial 12 S rRNA A1555G Mutation

Deletion of Gtpbp3 in zebrafish revealed the hypertrophic cardiomyopathy manifested by aberrant mitochondrial tRNA metabolism

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice.

Deficient Trna Posttranscription Modification Dysregulated the Mitochondrial Quality Controls and Apoptosis

A Coronary Artery Disease-Associated Trna(thr) Mutation Altered Mitochondrial Function, Apoptosis and Angiogenesis

Mitochondrial Dysfunction Caused by M.2336t > C Mutation with Hypertrophic Cardiomyopathy in Cybrid Cell Lines

Depletion of M6a Reader Protein YTHDC1 Induces Dilated Cardiomyopathy by Abnormal Splicing of Titin

Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient Ipsc-Derived Cardiomyocytes with MT-RNR2 Mutation.

Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK axis

Novel Role of Mitochondrial GTPases 1 in Pathological Cardiac Hypertrophy

Abstract 274: Mitochondrial Translation Machinery Defects Causes Cardiomyopathy and I N Vivo Functional Screening of Therapeutic Targets

MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast